González-Villalpando C

Language: Spanish
References: 11
Page: 80-81
PDF size: 86.83 Kb.

Text Extraction

No Abstract

REFERENCES

1. González-Villalpando C, Stern MP, Arredondo-Pérez B, Mitchell B, Valdez R, Haffner S. Prevalencia de diabetes mellitus e intolerancia a la glucosa en una población urbana de nivel económico bajo. Rev Invest Clin 1992;44:321-328.

2. Stern MP, González C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic an environmental determinants of type 2 diabetes in Mexico City and San Antonio. Diabetes 1992;41:484-492.

3. González-Villalpando ME, González-Villalpando C, Arredondo-Pérez B, Stern MP. Diabetic retinopathy in Mexico. Prevalence and clinical characteristics. Arch Med Res 1994;25:355-360.

4. González-Villalpando C, et al. Nephropathy in low income diabetics: The Mexico City Diabetes Study. Arch Med Res 1996;27(3):367-372.

5. González-Villalpando ME, González-Villalpando C, Arredondo-Pérez B, Martínez-Díaz SV, Mitchell B, Rivera-Martínez D, Klein R, Haffner SM,Stern MP. Moderate-to-severe diabetic retinopathy is more prevalent in Mexico city than San Antonio, Texas. Diabetes Care 1997;20(5): 773-777.

6. González-Villalpando C, González-Villalpando ME, Rivera MD, Stern MP. Incidencia y progre-sión de la retinopatía diabética en población de nivel socioeconómico bajo de la Ciudad de México. Rev Invest Clin 1999;51(3):141-150.

7. Burke JP, Williams K, Haffner SM, González-Villalpando C, Stern MP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared to Mexico City. Diabetes Care 2001;24(9):1573-1578.

8. González C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA. Clinical characteristics of type 2 diabetic subjects consuming high vs. low carbohydrate diets in Mexico City and San Antonio, Texas. Diabetes Care 1994;17:397-404.

9. González-Villalpando C, Stern MP, Arredondo-Pérez B. Utilización de servicios hospitalarios por pacientes diabéticos: estudio en población abierta. Salud Publica Mex 1994;36-(4):415-419.

10. Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM; Diabetes Prevention Program Research Group. Cost associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003;26(1)36-47.

11. Arredondo A, Zúñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Diabetes Care 27;(1):104-109.